Scott Peters
Comptroller/Controller/Auditor chez PLIANT THERAPEUTICS, INC.
Profil
Scott Peters is currently the Vice President-Finance & Controller at Pliant Therapeutics, Inc. Prior to his current position, he worked at Alexion Pharmaceuticals, Inc. as the Executive Director & Controller from 2013 to 2021.
Mr. Peters completed his undergraduate degree at the University of California, Santa Barbara.
Postes actifs de Scott Peters
| Sociétés | Poste | Début |
|---|---|---|
| PLIANT THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/02/2021 |
Anciens postes connus de Scott Peters
| Sociétés | Poste | Fin |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/02/2021 |
Formation de Scott Peters
| University of California, Santa Barbara | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PLIANT THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
